BenchSci Announces Launch of ASCEND™ – a First-of-its-Kind ‘Map’ of All Disease Biology that Aims to Transform Pharmaceutical Research

3 years ago

The SaaS solution is powered by proprietary machine-learning technology that reads and interprets data like a PhD scientist BenchSci ASCEND…

EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis

3 years ago

Focal One® HIFU treatment resulted in significant improvements in endometriosis symptoms and quality of life (QoL)Positive safety profile with 96.7% of…

Alignment Healthcare to Announce Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call Tuesday, Feb. 28, 2023

3 years ago

ORANGE, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, will release…

scPharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

3 years ago

BURLINGTON, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing…

aTyr Pharma to Present New Data on the Mechanism of Action of Efzofitimod at the American Thoracic Society 2023 International Conference

3 years ago

 Symposia presentation to highlight significant advancements in understanding of efzofitimod’s MOA Poster presentation analyzing exposure-efficacy of efzofitimod further supports clinical…

Ocugen, Inc. to Present at 2023 BIO CEO & Investor Conference

3 years ago

MALVERN, Pa., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused…

SeaStar Medical to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023

3 years ago

DENVER, Jan. 31, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical (Nasdaq: ICU), a medical technology company developing proprietary solutions to reduce…

DiagnaMed Holdings Provides Update for BRAIN AGE™ Development and Commercialization Milestones for 2023

3 years ago

Complete IRB-approved research study in Q2-2023 Commercialize BRAIN AGE™ in Q4-2023 TORONTO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- DiagnaMed Holdings…

Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status

3 years ago

Guidance Expands Number of Hospitals that Can Access IVL to Include Sites Where Calcium Modification Tools Were Previously Not RecommendedSANTA…

Publication Analyzes Clinical Efficacy of Deep TMS™ in Treating Different Brain Regions Associated with Major Depressive Disorder

3 years ago

Study Results Outline a Potential Path to More Personalized Medicine in Noninvasive Brain StimulationBURLINGTON, Mass. and JERUSALEM, Jan. 31, 2023…